|
|
||||||||||
|
J Am Coll Cardiol, 2002; 40:1848-1855 © 2002 by the American College of Cardiology Foundation |



||
* Department of Cardiology, Amsterdam, The Netherlands
Department of Clinical Physics and Informatics, Amsterdam, The Netherlands
Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
Institute for Cardiovascular Research ICaR-VU, Amsterdam, The Netherlands
|| Interuniversity Cardiology Institute Netherlands, Utrecht, The Netherlands
Manuscript received February 20, 2002; revised manuscript received June 9, 2002, accepted July 24, 2002.
* Reprint requests and correspondence: Dr. Willemijn L. F. Bedaux, Department of Cardiology, VU University Medical Center, Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
wlf.bedaux{at}VUmc.nl
| Abstract |
|---|
|
|
|---|
BACKGROUND: In patients after coronary artery bypass grafting (CABG), non-invasive testing may be helpful in the detection of recurrent graft disease.
METHODS: Randomly selected patients (n = 21) scheduled for X-ray angiography because of recurrent chest complaints after CABG were included for evaluation of vein grafts (n = 40) by CMR. Three-dimensional contrast-enhanced CMR angiography was performed and followed by flow measurements at rest and during hyperemia in patent grafts only. Flow reserve was calculated when resting flow exceeded 20 ml/min. Analysis was based on four categories defined by X-ray angiography: occluded grafts (n = 3), grafts with stenosis >50% (n = 19), grafts with stenosis <50% with diseased graft run-off (n = 8), and grafts with stenosis <50% and normal run-off (n = 10).
RESULTS: The CMR angiography demonstrated occlusion of three grafts. In nine of the 37 patent grafts, basal blood flow was <20 ml/min, all demonstrating significant stenosis at X-ray angiography. In grafts with resting flow >20 ml/min (n = 28), flow reserve significantly differed between grafts without stenosis and grafts with significant stenosis or with diseased run-off (2.5 ± 0.7 vs. 1.8 ± 0.9, p = 0.04). An algorithm combining basal volume flow <20 ml/min and graft flow reserve <2 had a sensitivity and specificity of 78% and 80% respectively for detecting grafts with significant stenosis or diseased run-off.
CONCLUSIONS: This feasibility study showed that quantification of flow and flow reserve by CMR may serve as a non-invasive adjunct to differentiate between vein grafts without stenosis and grafts with significant stenosis or diseased run-off.
| ||||||||
The capability of cardiovascular magnetic resonance (CMR) to assess patency of coronary artery vein grafts has been demonstrated (410). Limitations arise with regard to assessing obstructive disease and evaluating distal segments of sequential grafts, owing to insufficient spatial resolution, low signal-to-noise ratio, and cardiac motion. Adding information on flow (1114) and flow reserve (15,16) using velocity-encoded cine CMR may help to detect the presence of hemodynamically significant graft stenosis.
The purpose of this study was to determine the feasibility of measuring volume flow and flow reserve of saphenous vein bypass grafts using CMR in patients suspected of graft disease, and to assess the value of CMR-determined graft flow reserve in differentiating non-diseased grafts from grafts with a significant stenosis or diseased run-off.
| Methods |
|---|
|
|
|---|
The study was approved by the Medical Ethics Committee of the VU University Medical Center of Amsterdam, the Netherlands, and all participants gave informed consent.
CMR technique
The CMR was performed using a 1.5-Tesla whole body CMR system (Vision, Siemens, Germany), a phased array body receiver coil, and prospective electrocardiographic gating. First, a multislice two-dimensional breath-hold, double inversion, black blood turbo spin-echo sequence (repetition time 800 ms, echo time 44 ms; field of view 230 to 350 mm; matrix 176 x 256, slice thickness 5 mm) was applied in an axial plane at the level of the aortic root to visualize the origin of the grafts. The proximal segments of the grafts were identified from the typical sites of the aortotomy. The graft with the most superior origin from the aorta and coursing laterally from the main or left pulmonary artery was considered to anastomose with the circumflex artery or marginal branches. The next lower graft with a more anterior course immediately leftward from the main pulmonary artery was judged to anastomose with the left anterior descending artery or diagonal branches. The graft with the most inferior origin from the aorta, coursing next to the right atrium or atrioventricular groove was considered to anastomose with the right or posterior descending coronary artery.
Three-dimensional (3D) contrast-enhanced CMR angiography was applied using gadoliniumdiethylene triamine pentaacetic acid (dose 0.1 to 0.2 mmol/kg) for the assessment of the course and patency of the proximal parts of the grafts. More distal parts of sequential grafts were not visualized owing to limited coverage by the 3D volume slab or cardiac motion. Acquisition parameters used were repetition time 5 ms, echo time 2 ms, excitation angle 14°, matrix 96 x 256 to 124 x 256, slab thickness 100 to 110 mm, and 30 to 34 partitions. In-plane resolution ranged from 2.0 x 1.6 to 2.8 x 1.6 mm. A trigger-time delay of 50 to 250 ms was used to drive the acquisition toward diastole. For an optimal timing of the contrast arrival, the time to peak contrast was determined using a contrast test bolus in a transverse plane at the middle of the ascending aorta. When both 3D CMR angiography and turbo spin echo imaging showed an occlusion of the graft, flow measurements in this graft were not performed. Figure 1 shows the X-ray angiography (Fig. 1A) and the 3D contrast-enhanced CMR angiogram (Fig. 1B) of a patient with two stenoses in a jump graft anastomosed to the posterolateral branch of the circumflex and the posterior descending branch of the right coronary artery.
|
|
CMR flow analysis
The images were evaluated without knowledge of the X-ray angiography results. In patent grafts, flow velocity analysis was performed with an analytic software package (FLOW, Medis, Leiden, The Netherlands). The contour of the cross-sectioned graft was visually determined on a magnitude image. The area of the region of interest was kept constant over the cardiac cycle and repositioned at each time frame on the magnitude image. The phasic volume flow within the cross-sectional area was measured on the corresponding velocity image. Because a prospectively triggered electrocardiographic gating technique was applied, no measurements could be obtained during the final 50 to 100 ms of the cardiac cycle. To compensate for this lack of data, an interpolation was performed between the first and last phase. Volume flow was determined by averaging the phasic volume flow over the cardiac cycle. Graft flow reserve was calculated by the ratio of hyperemic volume flow divided by the basal volume flow. Graft flow reserve was not calculated when the absolute basal volume flow was below 20 ml/min as this would introduce relatively large errors at low flow values. The error in the flow reserve is determined by the relative error in the basal and stress flow measurements. These relative errors are large in the low velocity range because of absolute errors induced by limited signal-to-noise ratio and background noise. In a previously reported study, resting flow below 20 ml/min was indicative of significant graft disease (14). The total CMR flow analysis ranged from 5 to 10 min per graft.
X-ray coronary angiography
In all patients, conventional biplane angiography was performed with the Judkins technique. Grafts and native coronary arteries were imaged using manual contrast media injections in orthogonal views. Where graft narrowing was observed, percent lumen diameter stenosis was calculated from the cineangiograms using quantitative measurements on two orthogonal projections. Based on X-ray angiography, a classification was made into the following categories: I) occluded grafts; II) patent grafts with >50% luminal narrowing; III) grafts with luminal narrowing <50% and distal run-off to a coronary artery with a significant stenosis (>50%) or to a myocardial perfusion territory with old infarction (diseased graft run-off); and IV) grafts with luminal narrowing <50% and normal run-off.
Data analysis
All results are presented as mean ± standard deviation. Measurements on separate grafts within one patient are considered as independent in the analysis, because separate CMR acquisitions were performed for each graft. Statistical significance of differences between categories was determined with an unpaired Student t test; p < 0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Only a few studies concerning the functional evaluation of grafts have been performed. Galjee et al. (7,12) and Hoogendoorn et al. (14) provided basal flow quantification in normal and dysfunctional saphenous vein grafts, but their technique was limited by respiration movements. It appeared that a volume flow less than 20 ml/min was an indicator of early graft dysfunction (14). Single and sequential grafts are functionally different grafts as sequential grafts show significantly higher volume flow (7). In this study we found the same trend, but no differentiation in single and sequential grafts was performed to define a separate cutoff value for sequential grafts, because of the limited number of patients.
Differentiation between blood-flow limiting and non-limiting stenosis may be achieved by flow reserve measurements. Langerak et al. (15) described the correlation between Doppler and CMR velocity reserve for non-diseased grafts (n = 20) and stenotic grafts (n = 4) or grafts with a diseased run-off (n = 3). No significant difference was found because of the limited number of diseased grafts.
Other non-invasive tests have shown efficacy in the detection of ischemia, such as dobutamine stress echocardiography (18) and CMR (19), CMR first pass perfusion imaging with dipyridamole (20), and stress scintigraphy (21). As these approaches determine the myocardial contractile reserve and perfusion reserve respectively, they fundamentally differ from flow reserve measurements at the blood flow conduits.
This study shows the combined use of CMR angiography and quantification of basal volume flow and flow reserve in differentiating between non-significantly and significantly diseased venous grafts or graft run-offs. CMR is of potential value in the non-invasive evaluation of patients with previous bypass graft surgery and may help to decide whether to postpone or to proceed to X-ray angiography. In patients with angiographically proven graft stenosis, it may help to assess the functional severity of the graft stenosis, i.e., whether the graft stenosis is flow-limiting and requires revascularization.
Limitations and potential improvements. The CMR flow velocity measurements in multiple grafts during a 6 to 10-min stress test using short-acting adenosine require fast data acquisition, preferably within a breath-hold. The technique of breath-hold phase velocity quantification as used in this study has certain limitations, which may lead to variability of the results. First, it requires a long breath holding (20 to 35 s), which is difficult to obtain in every patient, especially during adenosine administration. The position of breath holding may vary, which can result in a different image position from that originally planned. Second, the technique has a large acquisition window that may result in image blurring because of cardiac motion when measurements are performed near the anastomosis (22). A shorter acquisition window is expected to lead to a higher accuracy, but this could not be achieved with the CMR system used. Improvements in CMR technology are currently under development. New gradient hardware and the application of spiral or echo planar imaging allow improvement in terms of spatial resolution (1 mm in-plane) and temporal resolution (acquisition window of 30 ms) (15).
In accordance with clinical guidelines at our institute, only patients with a high likelihood of recurrent coronary artery or bypass graft disease undergo X-ray angiography. This will affect the predictive value of the diagnostic test. A prospective follow-up study with clinical end points, which requires a large number of patients, has to be performed to overcome this limitation.
Flow measurements were restricted to saphenous vein grafts. CMR flow measurements in internal mammary grafts are feasible (11,23) but need to be derived at a very proximal position in the arterial grafts, as clip artifacts can influence the measurement at distal sites of the grafts. Flow reserve measurements of the saphenous vein grafts require imaging close to the heart. Both could not be performed during a 6-min stress test.
Although significant differences were found between flow reserve measurements in grafts without stenosis and grafts with significant stenosis or with diseased run-off, there was an overlap of the flow reserve values (Figs. 4 and 5). The overlap originates from the principle of flow reserve, which considers not only the physiologic significance of the coronary artery or bypass graft lesion but also the vascular bed including distal run-off and microvascular dysfunction. Because of variability of the vascular bed, it has been difficult to establish true normal values and to interpret flow reserve in individual patients (24,25).
In the heart, particularly in the presence of bypass grafts, blood supply to the myocardium can have many pathways, and as a result, measurement of flow in bypass grafts alone inadequately reflects total myocardial blood supply. Concurrent anterograde flow through grafted native coronary arteries may hamper the distinguishment between changes of flow velocity that originate from the graft or from the native coronary artery (26). Theoretically, competitive flow from a patent native vessel might affect the predictive accuracy of any testing based solely on graft flow. However, in this study patients were studied late postoperatively, and native coronary arteries were completely occluded in most.
In conclusion, this study shows the feasibility of CMR flow quantification to non-invasively differentiate between non-significantly diseased grafts and grafts that are significantly diseased or have a diseased graft run-off. The technique may become of clinical value to help in deciding whether or not to proceed to a further invasive evaluation.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. P. Salm, J. J. Bax, H. W. Vliegen, S. E. Langerak, P. Dibbets, J. W. Jukema, H. J. Lamb, E. K.J. Pauwels, A. de Roos, and E. E. van der Wall Functional significance of stenoses in coronary artery bypass grafts: Evaluation by single-photon emission computed tomography perfusion imaging, cardiovascular magnetic resonance, and angiography J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1877 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur. Heart J., November 1, 2004; 25(21): 1940 - 1965. [Full Text] [PDF] |
||||
![]() |
L. P. Salm, S. E. Langerak, H. W. Vliegen, J. W. Jukema, J. J. Bax, A. H. Zwinderman, E. E. van der Wall, A. de Roos, and H. J. Lamb Blood Flow in Coronary Artery Bypass Vein Grafts: Volume versus Velocity at Cardiovascular MR Imaging Radiology, September 1, 2004; 232(3): 915 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mavrogeni, G. Papadopoulos, M. Douskou, S. Kaklis, I. Seimenis, P. Baras, P. Nikolaidou, C. Bakoula, E. Karanasios, A. Manginas, et al. Magnetic resonance angiography isequivalent to X-Ray coronary angiography for the evaluation of coronary arteries in kawasaki disease J. Am. Coll. Cardiol., February 18, 2004; 43(4): 649 - 652. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |